12/14
09:07 am
cvs
Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus [Seeking Alpha]
Low
Report
Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus [Seeking Alpha]
12/14
07:23 am
cvs
Flu season is here. How much is the vaccine without insurance? [USA TODAY]
Low
Report
Flu season is here. How much is the vaccine without insurance? [USA TODAY]
12/13
08:08 am
cvs
These sick kids can't be home for the holidays. This influencer is trying to help. [USA TODAY]
Low
Report
These sick kids can't be home for the holidays. This influencer is trying to help. [USA TODAY]
12/12
09:37 am
cvs
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
Low
Report
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
12/12
08:03 am
cvs
CVS Health (NYSE:CVS) was given a new $87.00 price target on by analysts at Sanford C. Bernstein.
Low
Report
CVS Health (NYSE:CVS) was given a new $87.00 price target on by analysts at Sanford C. Bernstein.
12/11
11:50 am
cvs
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak [Yahoo! Finance]
Low
Report
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak [Yahoo! Finance]
12/11
11:30 am
cvs
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Low
Report
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
12/11
09:38 am
cvs
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a "buy" rating on the stock.
Medium
Report
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a "buy" rating on the stock.
12/11
08:17 am
cvs
Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector” [Yahoo! Finance]
Low
Report
Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector” [Yahoo! Finance]
12/10
10:56 pm
cvs
CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond. [Yahoo! Finance]
Low
Report
CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond. [Yahoo! Finance]
12/10
12:48 pm
cvs
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript [Seeking Alpha]
Low
Report
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript [Seeking Alpha]
12/10
12:17 pm
cvs
2025 Forbes Healthcare Summit | Improving The Patient Experience Part 2: At The Doctor's Office [Forbes]
Low
Report
2025 Forbes Healthcare Summit | Improving The Patient Experience Part 2: At The Doctor's Office [Forbes]
12/10
11:49 am
cvs
CVS Health Entering 2026 With Momentum and Visibility Into Mid-Teens EPS Growth Through 2028, RBC Says [Yahoo! Finance]
Low
Report
CVS Health Entering 2026 With Momentum and Visibility Into Mid-Teens EPS Growth Through 2028, RBC Says [Yahoo! Finance]
12/10
11:24 am
cvs
CVS Health Lifts Long-Term Growth Targets on PCW Profitability, Turnaround Progress, Morgan Stanley Says [Yahoo! Finance]
Low
Report
CVS Health Lifts Long-Term Growth Targets on PCW Profitability, Turnaround Progress, Morgan Stanley Says [Yahoo! Finance]
12/10
10:39 am
cvs
CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures [Yahoo! Finance]
Low
Report
CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures [Yahoo! Finance]
12/10
10:29 am
cvs
Cramer's Stop Trading: CVS Health [CNBC]
Low
Report
Cramer's Stop Trading: CVS Health [CNBC]
12/10
09:37 am
cvs
CVS Health (NYSE:CVS) had its price target raised by analysts at Mizuho from $88.00 to $95.00. They now have an "outperform" rating on the stock.
Low
Report
CVS Health (NYSE:CVS) had its price target raised by analysts at Mizuho from $88.00 to $95.00. They now have an "outperform" rating on the stock.
12/10
09:37 am
cvs
CVS Health (NYSE:CVS) had its price target raised by analysts at Truist Financial Corporation from $95.00 to $98.00. They now have a "buy" rating on the stock.
Low
Report
CVS Health (NYSE:CVS) had its price target raised by analysts at Truist Financial Corporation from $95.00 to $98.00. They now have a "buy" rating on the stock.
12/10
09:30 am
cvs
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
Low
Report
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
12/10
08:44 am
cvs
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
12/10
08:44 am
cvs
CVS Health (NYSE:CVS) was given a new $100.00 price target on by analysts at Truist Financial Corporation.
Low
Report
CVS Health (NYSE:CVS) was given a new $100.00 price target on by analysts at Truist Financial Corporation.
12/10
08:08 am
cvs
CVS Health (NYSE:CVS) had its price target raised by analysts at Robert W. Baird from $82.00 to $92.00. They now have an "outperform" rating on the stock.
Low
Report
CVS Health (NYSE:CVS) had its price target raised by analysts at Robert W. Baird from $82.00 to $92.00. They now have an "outperform" rating on the stock.
12/10
07:21 am
cvs
CVS Health (NYSE:CVS) had its "outperform" rating reaffirmed by analysts at UBS Group AG.
Low
Report
CVS Health (NYSE:CVS) had its "outperform" rating reaffirmed by analysts at UBS Group AG.
12/10
07:21 am
cvs
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/10
07:21 am
cvs
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.